First rheumatology Covid study published (Telemedicine) from community group surveys.03 November 2021 NRAS along with many other patient organisations helped promote this study back in March 2021, the results of which have now been published. Remote consultations:“Perfect for some but disastrous for others”: Patients and clinicians express concerns over phone and video consultations The Covid-19 pandemic necessitated a rapid move by health systems into the digital space and telemedicine; yet much remains unknown about telemedicine’s acceptability and safety in rheumatology. To help address this gap and inform practice, this study investigated rheumatology patient and clinician experiences and views of telemedicine. Surveys (Patients n = 1,340, Clinicians n = 111) and interviews (Patients n = 31, Clinicians n = 29) were completed between April 2021 and July 2021. Findings indicate a preference for face-to-face consultations. Some negative experiences may be due to the pandemic rather than telemedicine specifically, although the risk of greater diagnostic inaccuracies using telemedicine is unlikely to be fully resolved. Training, choice, careful patient selection, and further consultation with clinicians and patients is required to increase telemedicine’s acceptability and safety. The full study report was published on Monday 1 November 2021 in Rheumatology journal. To read the full paper, click here NRAS has conducted a recent survey on patient experiences of care during the pandemic including experience of remote consultations, the data from which is currently being analysed by University of Oxford who partnered with us on our survey and we hope will be published later this year.